Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation
Recruiting
N/A
Interventional Study
COPD (Chronic Obstructive Pulmonary Disease)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 50 (estimated)
- Sponsor
- University of Massachusetts, Worcester · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Chronic Obstructive Pulmonary Disease (COPD) is a serious lung condition that affects millions of people in the United States. Each year, it leads to about 150,000 deaths, nearly 900,000 emergency room visits, and 700,000 hospital stays. When COPD symptoms suddenly get worse-called an exacerbation-it can seriously harm a person's quality of life and often requires emergency care. Treating these fl…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
1. Diagnosis of COPD
2. At least one COPD exacerbation resulting in ED utilization in the six months prior to enrollment
3. COPD GOLD Score letter designation of B, C, or D
4. Receives care in the UMass Memorial Medical Center Pulmonary Clinic or Benedict Family Health Clinic
5.…
Contacts